Trending
- Stoke-on-Trent prostate screening event attended by 500 men
- Sustained MRD Negativity With DVRd Signals Long-Term Survival in NDMM
- Nursing Strategies for the 3 First-Line Regimens in EGFR-Mutated NSCLC
- Targeted Agents, Amyloidosis, and Defining a Cure in Plasma Cell Disorders
- How Can Literature and Peer Review Impact an Oncology Fellow’s Career?
- Joint Use of Rabbit ATG and poSt-tranSplant Immunosuppression with Cyclophosphamide, without any other graft-versus-host disease prophylaxis, for HLA-matched peripheral blood hematopoietic cell transplantation – The JURASSIC phase I trial
- Switching to SC Dosing and Considering PRO Data for Amivantamab in NSCLC
- Isatuximab Combo Increases MRD Negativity in MRD-Positive Multiple Myeloma
Friday, September 25